Not all clients with CLL call for therapy. Inspite of all current advancements, the iwCLL still recommends watchful observation for individuals with asymptomatic ailment.86 This advice is based on at least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 The two trials concluded https://emilyu371vcj8.glifeblog.com/profile